Human Bocavirus-1 infection: a closer look into its clinical and virological features
Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Cited by 2 publications
References 9 publications
Prevalence and molecular characterization of human bocavirus-1 in children and adults with influenza-like illness from Kunming, Southwest China
Human bocavirus-1 (HBoV-1) has been associated with respiratory infections in both children and adults, often presenting symptoms similar to those of influenza. Understanding the prevalence and molecular characteristics of HBoV-1 in individuals with influenza-like illness (ILI) is essential for enhancing the diagnosis and treatment of respiratory infections in Kunming, Southwest China. Between December 2017 and December 2023, demographic and clinical data, along with respiratory tract specimens from individuals aged 0 to 97 years with ILI, were collected at three sentinel hospitals in Kunming. Each specimen was tested for 18 respiratory viruses, and the positive rates of HBoV-1 across different age groups were analyzed. Amplification of the near-complete HBoV genome was achieved through three overlapping fragments, followed by next-generation sequencing (NGS) and phylogenetic analysis. A total of 20,181 respiratory samples were collected from patients aged 1 month to 97 years presenting with ILI symptoms between December 2017 and December 2023, with HBoV detected in 0.8% of the samples. The prevalence was 1.0% (165/16,406) in children and 0.1% (3/3,775) in adults, with a significantly higher detection rate in pediatric patients (<18 years old) compared to adults (≥18 years old) ( P < 0.001). Among the 168 HBoV-positive participants, 165 (98.2%) were children under 18 years, while 3 (1.8%) were adults. Genome-wide phylogenetic analyses indicated that HBoV-1 was the predominant genotype, showing that the HBoV-1 strains circulating in Kunming are closely related to strains from other regions of China and globally. Our findings confirm the prevalence of HBoV-1 in individuals with ILI in Kunming and provide valuable insights into the molecular characteristics of HBoV-1 in this region. Further studies are necessary to explore the clinical implications of HBoV-1 infection and its role in respiratory illnesses. IMPORTANCE Viral respiratory infections are a leading cause of morbidity- and mortality-associated influenza-like illness (ILI) cases. It is estimated that there are several billion cases of ILI globally each year. Monitoring data from China in 2023 indicate that there are approximately 17 million cases of ILI nationwide. In the United States, the annual incidence of ILI ranges from 9 to 49 million cases. Human bocavirus-1 (HBoV-1) has been identified as a causative agent of ILI. The global prevalence of HBoV-1 respiratory infections varies from 1% to 56.8%, with the majority of studies focusing on pediatric populations; however, research including a broader age range is limited. Currently, the prevalence of HBoV-1 in the Kunming area is not well characterized, and its molecular features remain inadequately described. This study aims to analyze the prevalence of HBoV-1 among ILI cases in Kunming, encompassing both pediatric and adult patients. We present 107 complete genomic sequences of HBoV-1 strains obtained from three ILI sentinel hospitals in the region. Furthermore, we conducted phylogenetic analysis, homology comparisons, and assessments of nucleotide and amino acid substitution site variations. These findings provide important insights for further investigations into HBoV-1 and its epidemiological significance.
Prevalence and molecular characterization of human bocavirus-1 in children and adults with influenza-like illness from Kunming, Southwest China
Human bocavirus-1 (HBoV-1) has been associated with respiratory infections in both children and adults, often presenting symptoms similar to those of influenza. Understanding the prevalence and molecular characteristics of HBoV-1 in individuals with influenza-like illness (ILI) is essential for enhancing the diagnosis and treatment of respiratory infections in Kunming, Southwest China. Between December 2017 and December 2023, demographic and clinical data, along with respiratory tract specimens from individuals aged 0 to 97 years with ILI, were collected at three sentinel hospitals in Kunming. Each specimen was tested for 18 respiratory viruses, and the positive rates of HBoV-1 across different age groups were analyzed. Amplification of the near-complete HBoV genome was achieved through three overlapping fragments, followed by next-generation sequencing (NGS) and phylogenetic analysis. A total of 20,181 respiratory samples were collected from patients aged 1 month to 97 years presenting with ILI symptoms between December 2017 and December 2023, with HBoV detected in 0.8% of the samples. The prevalence was 1.0% (165/16,406) in children and 0.1% (3/3,775) in adults, with a significantly higher detection rate in pediatric patients (<18 years old) compared to adults (≥18 years old) ( P < 0.001). Among the 168 HBoV-positive participants, 165 (98.2%) were children under 18 years, while 3 (1.8%) were adults. Genome-wide phylogenetic analyses indicated that HBoV-1 was the predominant genotype, showing that the HBoV-1 strains circulating in Kunming are closely related to strains from other regions of China and globally. Our findings confirm the prevalence of HBoV-1 in individuals with ILI in Kunming and provide valuable insights into the molecular characteristics of HBoV-1 in this region. Further studies are necessary to explore the clinical implications of HBoV-1 infection and its role in respiratory illnesses. IMPORTANCE Viral respiratory infections are a leading cause of morbidity- and mortality-associated influenza-like illness (ILI) cases. It is estimated that there are several billion cases of ILI globally each year. Monitoring data from China in 2023 indicate that there are approximately 17 million cases of ILI nationwide. In the United States, the annual incidence of ILI ranges from 9 to 49 million cases. Human bocavirus-1 (HBoV-1) has been identified as a causative agent of ILI. The global prevalence of HBoV-1 respiratory infections varies from 1% to 56.8%, with the majority of studies focusing on pediatric populations; however, research including a broader age range is limited. Currently, the prevalence of HBoV-1 in the Kunming area is not well characterized, and its molecular features remain inadequately described. This study aims to analyze the prevalence of HBoV-1 among ILI cases in Kunming, encompassing both pediatric and adult patients. We present 107 complete genomic sequences of HBoV-1 strains obtained from three ILI sentinel hospitals in the region. Furthermore, we conducted phylogenetic analysis, homology comparisons, and assessments of nucleotide and amino acid substitution site variations. These findings provide important insights for further investigations into HBoV-1 and its epidemiological significance.
Current landscape of cystic fibrosis gene therapy
Cystic fibrosis is a life-threatening disease that is caused by mutations in CFTR, a gene which encodes an ion channel that supports proper function of several epithelial tissues, most critically the lung. Without CFTR, airway barrier mechanisms are impaired, allowing for chronic, recurrent infections that result in airway remodeling and deterioration of lung structure and function. Small molecule modulators can rescue existing, defective CFTR protein; however, they still leave a subset of people with CF with no current disease modifying treatments, aside from lung transplantation. Gene therapy directed to the lung is a promising strategy to modify CF disease in the organ most associated with morbidity and mortality. It is accomplished through delivery of a CFTR transgene with an airway permissive vector. Despite more than three decades of research in this area, a lung directed gene therapy has yet to be realized. There is hope that with improved delivery vectors, sufficient transduction of airway cells can achieve therapeutic levels of functional CFTR. In order to do this, preclinical programs need to meet a certain level of CFTR protein expression in vitro and in vivo through improved transduction, particularly in relevant airway cell types. Furthermore, clinical programs must be designed with sensitive methods to detect CFTR expression and function as well as methods to measure meaningful endpoints for lung structure, function and disease. Here, we discuss the current understanding of how much and where CFTR needs to be expressed, the most advanced vectors for CFTR delivery and clinical considerations for detecting CFTR protein and function in different patient subsets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Contact Info
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Product
Resources
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.
